Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.39 |
| ▸ | DPP4 | P27487 | 14/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31268995 | 0.91 | DPP4 (0.40) | DPP4PIK3CDGPR119 | |
| SCHEMBL31268830 | 0.91 | DPP4 (0.35) | CNR1DPP4PIK3CDDGAT1GPR119 | |
| SCHEMBL31268747 | 0.90 | CNR1 (0.36) | CNR1CYP3A4PIK3CDDGAT1CNR2 | |
| SCHEMBL31269049 | 0.89 | GPR119 (0.37) | CNR1PIK3CDDGAT1CNR2GPR119 | |
| SCHEMBL31269290 | 0.89 | PIK3CD (0.37) | CNR1PIK3CDDGAT1CNR2 | |
| SCHEMBL31269102 | 0.88 | PIK3CD (0.35) | CNR1PIK3CDDGAT1CNR2GPR119 | |
| SCHEMBL31268964 | 0.88 | CNR1 (0.37) | CNR1DPP4CYP3A4PIK3CDGPR119 | |
| SCHEMBL31269194 | 0.87 | TLR7 (0.36) | PIK3CDDGAT1CNR2GPR119 | |
| SCHEMBL31269283 | 0.87 | PIK3CD (0.38) | CNR1PIK3CDDGAT1CNR2 | |
| SCHEMBL31268911 | 0.87 | GPR119 (0.36) | CNR1PIK3CDDGAT1CNR2GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4689155-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | Astrazeneca AB (SE) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024201368-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | ASTRAZENECA AB (SE) | 2024-10-03 | — | — | WO | disclosed |